Cargando…
Skin cancer in essential thrombocythaemia and polycythaemia vera patients treated with hydroxycarbamide
Hydroxycarbamide (HC) is used as a cytoreductive treatment in myeloproliferative neoplasms (MPN). Observational studies have raised the possibility that HC contributes to the development of secondary malignancies, including skin tumours in MPN patients. In this retrospective observational study, we...
Autores principales: | Mathur, Abhinav, Edman, Joakim, Liang, Livia, Scott, Neil W., Watson, Henry G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713223/ https://www.ncbi.nlm.nih.gov/pubmed/36467813 http://dx.doi.org/10.1002/jha2.551 |
Ejemplares similares
-
Masked polycythaemia vera is genetically intermediate between JAK2V617F mutated essential thrombocythaemia and overt polycythaemia vera
por: Tiong, I S, et al.
Publicado: (2016) -
Koilonychia and Polycythæmia Vera
por: Glazebrook, A. J.
Publicado: (1944) -
Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys)
por: Okikiolu, Jumoke, et al.
Publicado: (2022) -
The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double‐blind, double‐dummy, symptom study (RELIEF)
por: Mesa, Ruben, et al.
Publicado: (2016) -
Headache in essential thrombocythaemia
por: Frewin, R, et al.
Publicado: (2012)